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Abstract
Background: Uveal melanoma is the most common primary intraocular tumor in adults in western countries. It is associated
with very severe visual morbidity and may lead to distant metastases even after successful treatment of the primary tumor.
In order to gain better insight into molecular mechanisms related to tumorigenesis and metastasis of uveal melanoma, we
used next-generation sequencing technology (SOLiD, Life Technologies) to acquire global transcriptome alteration between
posterior uveal melanoma cells and normal uveal melanocyte.
Results: From mRNAs of the cultured uveal melanoma cells and normal uveal melanocytes, we annotated more than
3.7610
7 and 2.7610
7 sequencing tags based on human Ensembl databases, respectively. For detailed analysis, we chose
5155 well-annotated genes mainly involved in the MAPK signaling pathway, cell cycle, cell adhesion junction, apoptosis, and
P53 signaling pathways as well as melanogenesis. In an effort to confirm the authenticity of our sequencing results, we
validated twenty-one identically differentially expressed genes by using quantitative real time PCR from cultured cell lines of
other posterior uveal melanoma cells and normal uveal melanocytes.
Conclusion: We have identified a large number of potentially interesting genes for biological investigation of uveal
melanoma. The expression profiling also provides useful resources for other functional genomic and transcriptome studies.
These 21 potential genes could discriminate between uveal melanoma cells and normal uveal melanocyte, which may be
indicative of tumorigenesis process. Our results further suggest that high-throughput sequencing technology provides a
powerful tool to study mechanisms of tumogenesis in the molecular level.
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Introduction
Uveal melanoma (UM) is an intraocular malignant tumor
occurring mainly in adult Caucasian and originates from melano-
cytes of the choroid, iris, and ciliary body [1,2]. Most of UMs (95%)
are posterior UM (locating in the ciliary body and choroid). Over a
25-year period from 1973 to 1997, incidence of UM in the United
State has been determined to be 4.3 cases per million people per
year, which is similar to the report from European countries [3].
Though UM is relatively rare compared with other malignant
tumors, it contributes to a large proportion of death rates and leads
to distant metastases even after successful treatment of the local
tumors [4]. Effective prevention and treatment of metastatic UM
remain elusive until now and overall survival rate of patients with
UM has not decreased in the past decades [5,6].
Early studies mainly focused on the cytogenetic variation and
chromosomal alterations of UM. The ploidy states of UM cells
indicate that aneuploidy is associated with epithelioid cell type
[7,8]. Aneuploidy of UM is a signal for poor clinical prognosis with
an increased rate of mortality [9,10,11]. Subsequent researchers
found that loss of chromosome 3 (monosomy 3) and gain of
chromosome 8q were associated significantly with high death rates
of UM [12] and the loss of 6p was a specific character of primary
UM metastases [13,14].
In the past decades, various gene mutations have been reported
in cutaneous melanoma, including BRAF, NRAS, p16
(CDKN2A), p53, PTEN, etc [15]. None of these gene mutations
have been detected in posterior UM [16]. Recently, it has been
reported that mutation of GNAQ gene (gene encodes heterotri-
metric G protein alpha-subunit) occurred in approximate 50% of
UM patients, but not in cutaneous melanoma [17].
In the stage of molecular studies, oncogenesis of UM is
considered to be a multistep, complicated process due to excessive
acquired or inherited genetic alterations that result in abnormal
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functional alternations have been found in related pathways,
including cell cycle [20], apoptosis [21] and P53 pathway [22,23].
In the meantime, several regulation factors have been found and
applied as the diagnostic markers in clinical and histopathologic
examinations, such as P53, Ki-67, Laminin Receptor 1 (LAMR1),
Endothelin 2 (ET2), Von Hippel Lindau Binding Protein 1 (VBP1)
and Cullin 2 (CUL2) [24,25,26].
To further survey molecular mechanism of UM and to
understand the oncogenesis of UM, we used the recently-
developed RNA-seq method to identify and quantify different
gene expression between UM cells and normal uveal melanocyte
(NUM) so that we could interrogate the dynamic variation of UM
transcriptome [27]. Our data demonstrated a greatly transforma-
tion of transcriptional activity in the whole genome scale of UM as
compared with NUM, leading directly to the up-regulation and
down-regulation of thousands of genes involved in various
important functional pathways. The most apparent disturbances
of multiple functional pathways other than the cell cycle,
apoptosis, and P53 signal pathways include mitogen-activated
protein kinase (MAPK) signaling pathway, cell adhesion junction,
and melanogenesis pathways. In an effort to validate the authority
of SOLiD data, quantitative real-time PCR (qRT-PCR) analysis
on several differently expressed genes was used in cell lines from
distinct UM and NUM specimens.
Materials and Methods
Source of the samples
The human uveal melanoma cell line M23 were isolated from
Caucasian patients with primary choroid melanoma using
methods described previously by us [28], grown in Dulbecco
Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA)
supplemented with 10% fetal Bovine Serum (FBS; Invitrogen-
Gibco, Carlsbad, CA) and incubated at 37uC in a humid
incubator containing 5% CO2. The human melanocyte cell line
UM-U-95 was obtained from the choroid of healthy Caucasian
donor eyes using the methods we described previously [29]. All
studies and procedures involving human tissue were approved by
the Wenzhou Medical College Institutional Review Board. Patient
samples involved in this study were used in accordance with the
tenets of the Declaration of Helsinki adopted by the World
Medical Association, 1964. Written consent was obtained from
every patient after being fully informed of the purpose of the study.
RNA extraction and library construction
About 5–10610
6 cultured cells were used for the isolation of
total RNA by Trizol Reagent (Invitrogen, Carlsbad, CA) at no less
than 1 mg. High-quality mRNA of each samples were extracted
with the Oligotex mRNA Spin-Column Kit, following the
protocols of the manufacturer (QIAGEN, Valencia, CA). After
the fragmentation of mRNA, 50–150 nt cleanup fraction were
collected for hybridization and reverse transcription. Then, the
cDNA library was amplified, cleaned with Qiagen MinElute PCR
purification Kit (QIAGEN, Valencia, CA) and purified on a native
6% polyacrylamide gel. Different PCR primers with correspond-
ing barcodes were connected with cDNAs for the PCR
amplification. About 140–200 bp cDNA (corresponds to about
50–110 nt mRNA) were excised by PAGE and then concentrated
into 10 ml after purification. Library examination was required
and the results of more than 80% proportion mRNA in
each library could be used for subsequent SOLiD sequencing
(Table S1).
SOLiD sequencing and alignment strategy
Both libraries were sequenced using SOLiD (Applied Biosys-
tems, Foster City, CA) sequencing technology. Over 500 pg
cDNA of each library was driven onto 1-mm-diameter beads using
emulsion PCR. The corresponding barcode primers representing
different samples enable us to run two completely independent
samples in a single run. We sequenced more than 4610
7 tags on a
SOLiD sequencing, approximately 70% of which were high-
quality sequence tags 35 nt in length.
The SOLiD alignment software (Applied Biosystems, Foster
City, CA) translates the reference sequence to di-base encoding
(‘‘color-space’’) and aligns the reads in color space, which avoids
leading to the scale-up mismatches. The software guarantees
finding all alignments between the reads and the reference
sequences with up to M mismatches (a user-specified parameter).
Construction of reference database and annotation
Reference database were made respectively by ribosomal RNA
and human chromosome database. Since parts of mature mRNAs
originated from diverse exons owing to alternative splicing, exon
junction database was created to annotate these categories of
transcripts. The exon junction database was composed by the
randomly combination of 34 bp sequences near the exonic
junction points. Low-quality reads (with the average quality value
below 8) were filtered and the remaining reads were used for
further mapping steps.
The 35 bp data were firstly matched with ribosomal RNA
database to wipe off the disturbance of remnants of rRNA. The
left data were then aligned with Human genome and exon
junction database for annotation successively, with the allowance
of three mismatches. The last 5 bp were cut off from unmapped
tags for the next matching with chromosome and exon junction
database (allowing two mismatches) to increase annotation rate of
raw data. Similar 25 bp matching with was made after the 30 bp
alignment as well. The two libraries tags were mapped to the
Human genome (Ensembl database) allowing up to three
mismatches for each read. Finally, after these three steps, tags
with matching information were collected for subsequent biolog-
ical analysis.
Biological analysis methods
Gene expression profiling analysis was based on the number of
tags matching with exon regions. Genes matched with more than
one tag on exon regions were considered to be expressed in our
statistical method. Also, RPKM (reads per kilobase of exon model
per million mapped reads) were used to evaluate the expressed
value and quantify transcript levels [30].
Functional classes were assigned according to GO (Gene
Ontology) mapping provided by the Ensembl database. DEGseq
program was used to make statistical analysis for the differentiated
gene expression between the two samples [31]. Genes with p-value
less than 0.01 were considered to be distinctly expressed. KEGG
analysis was based on the comparative results between our
mapping genes and the updated KEGG database [32,33].
GenMAPP 2.0 and PathVisio were respectively used to evaluate
differentiated gene expression in a variety of biological pathways
[34,35].
Quantitative real-time PCR analysis
The samples for qRT-PCR were derived from the human
posterior UM cell lines M17, M21, M23, and SP6.5 (provided by
Guy Pelletier, Research Center of Immunology, Quebec,
Canada), which were isolated from Caucasian patients with
Transcriptomic Analysis on Uveal Melanoma
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above method described previously [36,37]. The human melano-
cyte cell lines UM-U-90, UM-U-94, UM-U-95, UM-U-97, UM-
U-106 were isolated and cultured as previously described as well
[28,29]. All studies and procedures involving human tissue were
approved by the Wenzhou Medical College Institutional Review
Board. Patient samples involved in this study were used in
accordance with the tenets of the Declaration of Helsinki (adopted
by the World Medical Association, 1964).
Gene sequences were obtained from the National Center for
Biotechnology Information (NCBI) with the primer design detailed
in Table S2. For qRT-PCR analysis, total RNA was extracted
based on the Trizol protocol (Invitrogen, Carlsbad, CA), treated
with DNAase I(Promega, Madison, WI), and reverse-transcribed
to cDNA (random priming) by using a standard protocol
(SuperScript II reverse-transcriptase, Invitrogen, Carlsbad, CA).
The PCRs were performed in an Applied Biosystems 7500
quantitative Real-Time PCR System using 26 SYBRH Green
PCR Master Mix (Applied Biosystems, Foster City, CA). The
initial denaturation reaction conditions for qRT-PCR were 50uC
for 2 minutes and 95uC for 10 minutes, followed by 40
amplification cycles at 95uC for 15 s, 60uC for 60 s, and 68uC
for 40 s.
Each sample was analyzed in duplicate with the volume of a
single reaction added up to 15 ml which contained 20 ng template
and a final primer concentration of 0.6 mM. 18 s rRNA (18 s
Ribosome RNA) was used as internal reference genes for
semiquantitative analysis.
Independent Samples T Test (SPSS Version 16.0) was used to
evaluate differences of mRNA expression between groups of UM
cells and NUM. The difference was defined as significant at
p,0.05 and highly significant at p,0.01.
Results
Characterization of the two cDNA libraries
In order to obtain a thorough survey of the transcriptome of
UM, we used NUM as the controls and sequenced both of them to
a depth of more than 50 million reads for analysis (Table 1). A
total of 84,591,386 and 47,744,976 tags were sequenced separately
via the strategy of filtering low-quality reads. After discarding
remnant rRNA from the two libraries, we mapped these tags
(,35 bp in length) to the human genome and a database of unique
exon-junction sequences, using the ABI SOLiD sequencing
system. We adopted the dual-matching strategy to ensure
capturing of both exonic expression and combinatorial exon
usage for all loci. To maximize tag-mapping accuracy and
coverage, we made triplicate-alignment strategy and only used
high-quality sequences of at least 25 nt. In the library of UM,
37,964,619 tags in all were mapped to specific locus of
chromosome or exon-junction database, of which 33,238,428
were focused on multiple regions and 4,726,191 were on unique
region. In comparison of NUM library, 27,011,204 tags were
mapped to specific locus of chromosome or exon-junction
database, including 6,102,251 unique mapping regions and
20,908,953 multiple mapping regions. Both of the mapping rates
of the two libraries were almost 50%.
Tags mapping to unique locus were used to analyze the
distribution of transcripts. Based on Ensembl dataset, we found
that 76.36%–83.56% transcripts were located from exon region
and 16.06%–6.53% transcripts were from intron region in two
libraries. Meanwhile, the residual of over 6% tags were from gene
region of anti-sense strand (Table 1).
Gene profiling and the category of highly-expressed
genes in two libraries
After mapping triplicate-alignment strategy, 19,515 and 19,714
genes were annotated with detailed information. To avoid the
influence of background noise and sequencing errors, genes with
more than one tag annotated on exon regions were considered
expressed. According to strict statistical strategy of annotation, we
confirmed 14,201 and 14,236 expressed genes in two libraries,
respectively. From the most abundant genes, we discovered that
most of them were related to melanocyte pathphysiological
changes relevant to metabolisms of cell cycle and apoptosis
(Table S3), which were associated with these two cell types.
Functional distribution of differentially-expressed genes
Up- and down-regulated genes were considered to be essential
determinants of tumor development. To better survey the
biological behavior of tumor growth and progression, it is
necessary to familiarize with the functional distribution of these
differentially-expressed genes in malignancies, compared to the
normal tissue.
Proceeding normalization of the two libraries by DEGseq
program, uniquely mapped reads with one gene annotation in
genome were used to identify corresponding RPKM of the gene.
Based on the values of RPKM, 9,335 differentially expressed genes
with p,0.01 were found between the two libraries. Though the
number of expressed genes in two libraries was nearly the same,
5,155 genes (with p,0.01 and fold change value.2) were found to
have extremely distinct expression, in which 3,802 genes were up-
regulated and 1,353 down-regulated in UM cells compared to
NUM.
Based on the analysis of GO categories, these 5,155 differen-
tially-expressed genes were categorized into three major functional
groups: cellular component, molecular function, and biological
process. The abundant genes were categorized into 17 major
functional groups (Percentage of expressed genes.10) based on
the GO categories after exclusion of crystallin, rRNA, and
mitochondrial genes. The top six functional categories include
metabolic process, cellular process, cell, organelle, binding, and
catalytic activity (Figure 1). The third level GO categories were
consistent with these results and provided more information on
cellular functions and subcellular locations. The major functional
groups based on these categories included intracellular, mem-
brane-bound organelle, ion binding, hydrolase activity, nucleic
Table 1. Tag mapping summary.
Read mapping UM NUM
Raw tag number 92,718,536 55,464,728
High-quality reads 84,591,386 47,744,976
35 bp mapped reads 13,042,363 10,522,399
30 bp mapped reads 12,925,983 9,316,993
25 bp mapped reads 11,996,273 7,171,812
Reads Mapped to unique locus 4,726,191 6,102,251
Reads Mapped to multiple loci 33,238,428 20,908,953
Annotated tag number 37,964,619 27,011,204
Annotation rate 44.88% 56.57%
Unique reads mapped to exon 3,608,762 5,099,313
Unique reads mapped to intron 759,012 398,644
doi:10.1371/journal.pone.0016516.t001
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ecule metabolic localization, primary metabolism process, trans-
lator cell communication, regulation of cellular process, and
organismal physiologic process. Furthermore, it has been found
that major functional categories of up-regulated genes in UM
included metallochaperone activity, nutrient reservoir activity, and
protein tag, which indicated that occurrences of UM or metastatic
propensity is correlated with increased synthesis of certain
proteins.
Expression coverage of susceptive chromosome
Chromosome 3 deletion is found in several cancers, monosomy 3
is the most common abnormality of chromosomes in the
pathogenesis of UM, which has been found to be associated with
UM metastasis. However, only a few reports described the loss of
heterozygosity of this chromosome. We could not find extreme
deletion of chromosome 3, while the expression values of UM in
chromosome 3 were lower than NUM (Figure 2). Meanwhile, the
UMexpressed region had a range wider than NUM, which reflected
that the mutation rate may be higher than normal cells (Table 2).
Previous atudies have reported interstitial or translocation of
certain regions (mainly 3p25.1 to 3p25.2) in chromosome 3 in
UM. We used transcripts annotated between 3p25.1 to 3p25.2 to
analyze the expression difference in this region by UCSC
(Figure 3). According to NCBI annotation, 43 genes are mapped
to the region (Build 34 version 1, found at NCBI). From Figure 3,
we found that the importance of this region was due to the
expression variation of corresponding oncogenes and tumor
suppressor genes.
Discussion
Variation of biological pathways related to UM
The transferred process from NUM to malignant posterior UM
is not induced by one metabolism pathway, but as a result of
alterations of multiple biological pathways that are from the
mutation of multiple oncogenes and turmor suppressor genes.
During the metastatic process of melanoma, involved pathways
are mainly composed of the following: MAPK signaling pathway,
cell cycle, p53 signaling pathway, apoptosis, and melanogenesis.
Figure 1. Functional categorization of differentially expressed genes based on known genes in the Uniprot database. Gene Ontology
(GO) terms at the 2nd level were plotted here, and in this ontology, ‘‘Cellular component’’, ‘‘Molecular function’’, and ‘‘Biological process’’ are
categorized independently. The purple and red pillars represent the up-regulated genes and down-regulated genes, separately.
doi:10.1371/journal.pone.0016516.g001
Figure 2. Distributions of differentially expressed genes in chromosome 3 compared with RefSeq Genes, GC content, and CpG
Islands.
doi:10.1371/journal.pone.0016516.g002
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extreme remarkable differentiation and uniquely described
information to annotate the relative protein or transcript of these
pathways, which was expected to describe the variation of gene
expression in relative biological pathways.
MAPK signaling pathway is a basic signal transduction
pathway that couples intracellular responses to the binding of
growth factors to cell surface receptors, which regulates the cell
proliferation, survival, differentiation and apoptosis [38]. MAPK
signaling pathway is composed of three different major signaling
pathway—ERK, JNK and p38. GNAQ mutation is detected in
half of UM clinical cases but has not been found in cutaneous
melanomas [39]. This mutation induces activation of one of the
MAPK signal pathways (ERK1/2) and upregulation of PKA
[40]. In our analysis (Figure 4), we found that RAS up-
regulation activated the expression of ERK by multiplex
phosphorylation, which finally regulate the mitosis by activating
MARK. The lack of BRAF mutations in posterior UM predicates
that missense mutations of BRAF is not related to the unlimited
cell proliferation in UM, which is differnt from the pathogenesis
of cutaneous melanoma. It may reflect that the pathogenesis of
uveal melanoma is not completely identical with cutaneous
melanoma.
The cell cycle is an ordered, tightly regulated process that takes
place in a cell leading to its division and duplication (replication)
[41]. Some proteins related to Cyclins, RB, and p53, are
checkpoints that control cell cycle progression of UM [20].
Checkpoint loss results in genomic instability and has been
implicated in the transformation of normal cells into cancer cells
[42]. There were alternation of expression of 103 genes in cell
cycle pathway, in which 75 genes were up-regulated, and 28 genes
were down-regulated (Figure 5). Most of the up-regulated genes
were related to DNA synthesis and transcriptional activation in
different phases of cell cycle. Furthermore, the expressions of
transcriptional inhibitors were evidently reduced, like cdkn2a,
cdkn1a, cdkn1b and mad1l2. We particularly noticed the deregula-
tion of the retinoblastoma gene (Rb), whose protein product is the
prototype tumor suppressor gene by virtue of its central role in
regulating the cell cycle [43]. In most other malignancies, Rb is
functionally inactivated by inappropriate phosphorylation result-
ing from deregulation of upstream effectors in the Rb pathway (eg,
p16 inactivation or cyclin D overexpression) [44]. In our analysis,
we concluded that Rb may be functionally inactivated in UM as a
result of cyclin/cdk complex phosphorylation that blocks its tumor
suppressor activity. This would then lead to inactivation and
ceaselessness of cell division in UM cells.
Apoptosis is an important mechanism for maintaining cellular
homeostasis, preventing the accumulation of deleterious muta-
tions, and averting malignant transformation [45]. The process of
apoptosis is controlled by a diverse range of cell signals, which may
originate either extracellularly (toxins, hormones, growth factors,
Table 2. Tag expression information of Chromosome 3
between UM and NUM.
Sample UM NUM
Start 123964 98702
End 197900737 197810160
Expression values 778303.04 599828.29
Bases covered 969,900 (0.49%) 746,095 (0.38%)
Minumum value 0.21 0.16
Maximum value 157 105.21
Range 156.79 105.05
Mean value 0.802457 0.803957
Variance 6.18828 6.6656
Standard deviation 2.48763 2.58178
Database GRCh37/hg19 GRCh37/hg19
doi:10.1371/journal.pone.0016516.t002
Figure 3. Distributions of differentially expressed genes in the region of 3p25.1 to 3p25.2 in chromosome 3.
doi:10.1371/journal.pone.0016516.g003
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cells can become resistant to apoptosis by activating proteins that
protect the cell from apoptosis, by mutating proteins that cause
apoptosis or by developing the ability to ignore apoptotic signals.
Apoptosis mechanisms pathway displayed the most of genes
expressions changes, which were 35 genes were up-regulated and
33 genes wee down-regulated (Figure 6). The initiation of
apoptotic mechanisms was induced by the activation of TNF
receptor or Fas receptor [47,48]. The down-expression of these
receptors (like TNFRSF1A, TNFRSF2A and TRADD) in UM
restricted the combination reaction with other cells that have
relative ligands. Furthermore, Fas receptor (also known as Apo-1 or
CD95) binds the Fas ligand (FasL), a transmembrane protein part
of the TNF family [47]. The interaction between Fas and FasL
results in the formation of the death-inducing signaling complex (DISC),
which contains the FADD, caspase-8 and caspase-10. From the
analysis (Figure 6), down-regulation of related caspases in UM
inhibites the ongoing apoptosis and activates pondent antiapop-
tosis mechanisms.
P53 is a key apoptotic regulator that is mutated in most kinds of
human cancer [49,50,51]. Its inactivation, induced by a number of
stress signals, including DNA damage, oxidative stress and
activated oncogenes, always results in three major outputs: cell
cycle arrest, cellular senescence or apoptosis [52]. According to
our analysis in cell cycle pathway, the inactivation of P53 leads to
the continual process of DNA damage cell from G1 to S without
proper repair. With the down-regulation of P53 (Figure 7), other
p53-relatived genes could not communicate with adjacent cells,
repair the damaged DNA or set up positive and negative feedback
loops that efficiently open up the pathway of apoptosis.
Melanogenesis is under complex regulatory control by multiple
factors. The most important positive regulator of melanogenesis is
the MC1 receptor with its ligands melanocortic peptides [53]. It
has been reported that MC1R was expressed in 95% of UMs and
no staining could be found in adjacent normal tissues [54]. MC1R
activates the cyclic AMP (cAMP) response-element binding
protein (CREB). Increased expression of MITF and its activation
by phosphorylation (P) stimulate the high-regulated transcription
Figure 4. Different genes expression in MAPK signaling pathway. Red and green represent up-regulated and down-regulated genes,
individually. The regulation extents are based on the color grade.
doi:10.1371/journal.pone.0016516.g004
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dopachrome tautomerase (DCT), which is involved in tyrosine
metabolism in melanosomes to produce melanin (Figure 8).
Furhtermore, it has been reported that MC1R induces phosphor-
ization of ERK [55], which may cause unlimited cell proliferation
and oncogenesis.
Quantitative real time PCR expression profiling of
selected genes
To prove the authenticity of the SOLiD, the expression levels of
selected genes were validated on cultured cell lines from other cell
lines of posterior UM and NUM by qRT-PCR. Thirty-one
candidate genes (Table S2) have been randomly selected from
genes that were differentially expressed throughout SOLiD
sequencing. We also used one endogenous control 18 rRNA to
exclude possible influences of regulation. The qRT-PCR results
confirmed that 21 of them showed identical gene expression
patterns as what were found via SOLiD sequencing technique
(Table S4). Eight genes that failed to be validated in qRT-PCR
were poorly expressed genes.
Comparing the expression data of RNA-Seq, qRT-PCR was
sufficiently sensitive to confirm high expressed genes, and the
results were identical with SOLiD data; however, it was not as
sensitive in the detection of low-expressed genes, which may lead
to the unsuccessful validation of the nine genes. Therefore, we
make the conclusion that qRT-PCR is not as sensitive detecting
low expressed genes when compared to SOLiD sequencing
technology.
Conclusions
Throughout the present study, we found a large number of
potentially interesting genes for biological investigation of UM.
The expression profiling suggests that the formation of UM occurs
along with the variation of several metabolisms, such as MAPK
Figure 5. Different genes expression in cell cycle. Red and green represent up-regulated and down-regulated genes, individually. The
regulation extents are based on the color grade.
doi:10.1371/journal.pone.0016516.g005
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individually. The regulation extents are based on the color grade.
doi:10.1371/journal.pone.0016516.g006
Figure 7. Different genes expression in P53 signaling pathway. Red and green represent up-regulated and down-regulated genes,
individually. The regulation extents are based on the color grade.
doi:10.1371/journal.pone.0016516.g007
Transcriptomic Analysis on Uveal Melanoma
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16516signal pathway, cell cycle, apoptosis, P53 pathway and melano-
genesis. Our study indicates that SOLiD is a useful technique for
functional genomic and transcriptome research of various tumor.
In the meantime, several potential markers were found to
discriminate between between UM and NUM.
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